Cargando…

Metabolic differentiation and classification of abnormal Savda Munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics

BACKGROUND: Abnormal Savda Munziq (ASMq) is a traditional Uyghur herbal preparation used as a therapy for abnormal Savda-related diseases. In this study, we investigate ASMq's dynamic effects on abnormal Savda rat models under different disease conditions. MATERIALS AND METHODS: Abnormal Savda...

Descripción completa

Detalles Bibliográficos
Autores principales: Mamtimin, Batur, Xia, Guo, Mijit, Mahmut, Hizbulla, Mawlanjan, Kurbantay, Nazuk, You, Li, Upur, Halmurat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621637/
https://www.ncbi.nlm.nih.gov/pubmed/26600713
http://dx.doi.org/10.4103/0973-1296.165551
_version_ 1782397467629715456
author Mamtimin, Batur
Xia, Guo
Mijit, Mahmut
Hizbulla, Mawlanjan
Kurbantay, Nazuk
You, Li
Upur, Halmurat
author_facet Mamtimin, Batur
Xia, Guo
Mijit, Mahmut
Hizbulla, Mawlanjan
Kurbantay, Nazuk
You, Li
Upur, Halmurat
author_sort Mamtimin, Batur
collection PubMed
description BACKGROUND: Abnormal Savda Munziq (ASMq) is a traditional Uyghur herbal preparation used as a therapy for abnormal Savda-related diseases. In this study, we investigate ASMq's dynamic effects on abnormal Savda rat models under different disease conditions. MATERIALS AND METHODS: Abnormal Savda rat models with hepatocellular carcinoma (HCC), type 2 diabetes mellitus (T2DM), and asthma dosed of ASMq. Serum samples of each animal tested by nuclear magnetic resonance spectroscopy and analyzed by orthogonal projection to latent structure with discriminant analysis. RESULTS: Compared with healthy controls, HCC rats had higher concentrations of amino acids, fat-related metabolites, lactate, myoinositol, and citrate, but lower concentrations of α-glucose, β-glucose, and glutamine. Following ASMq treatment, the serum acetone very low-density lipoprotein (VLDL), LDL, unsaturated lipids, acetylcysteine, and pyruvate concentration decreased, but α-glucose, β-glucose, and glutamine concentration increased (P < 0.05). T2DM rats had higher concentrations of α- and β-glucose, but lower concentrations of isoleucine, leucine, valine, glutamine, glycoprotein, lactate, tyrosine, creatine, alanine, carnitine, and phenylalanine. After ASMq treated T2DM groups showed reduced α- and β-glucose and increased creatine levels (P < 0.05). Asthma rats had higher acetate, carnitine, formate, and phenylalanine levels, but lower concentrations of glutamine, glycoprotein, lactate, VLDL, LDL, and unsaturated lipids. ASMq treatment showed increased glutamine and reduced carnitine, glycoprotein, formate, and phenylalanine levels (P < 0.05). CONCLUSION: Low immune function, decreased oxidative defense, liver function abnormalities, amino acid deficiencies, and energy metabolism disorders are common characteristics of abnormal Savda-related diseases. ASMq may improve the abnormal metabolism and immune function of rat models with different diseases combined abnormal Savda.
format Online
Article
Text
id pubmed-4621637
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-46216372015-11-23 Metabolic differentiation and classification of abnormal Savda Munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics Mamtimin, Batur Xia, Guo Mijit, Mahmut Hizbulla, Mawlanjan Kurbantay, Nazuk You, Li Upur, Halmurat Pharmacogn Mag Original Article BACKGROUND: Abnormal Savda Munziq (ASMq) is a traditional Uyghur herbal preparation used as a therapy for abnormal Savda-related diseases. In this study, we investigate ASMq's dynamic effects on abnormal Savda rat models under different disease conditions. MATERIALS AND METHODS: Abnormal Savda rat models with hepatocellular carcinoma (HCC), type 2 diabetes mellitus (T2DM), and asthma dosed of ASMq. Serum samples of each animal tested by nuclear magnetic resonance spectroscopy and analyzed by orthogonal projection to latent structure with discriminant analysis. RESULTS: Compared with healthy controls, HCC rats had higher concentrations of amino acids, fat-related metabolites, lactate, myoinositol, and citrate, but lower concentrations of α-glucose, β-glucose, and glutamine. Following ASMq treatment, the serum acetone very low-density lipoprotein (VLDL), LDL, unsaturated lipids, acetylcysteine, and pyruvate concentration decreased, but α-glucose, β-glucose, and glutamine concentration increased (P < 0.05). T2DM rats had higher concentrations of α- and β-glucose, but lower concentrations of isoleucine, leucine, valine, glutamine, glycoprotein, lactate, tyrosine, creatine, alanine, carnitine, and phenylalanine. After ASMq treated T2DM groups showed reduced α- and β-glucose and increased creatine levels (P < 0.05). Asthma rats had higher acetate, carnitine, formate, and phenylalanine levels, but lower concentrations of glutamine, glycoprotein, lactate, VLDL, LDL, and unsaturated lipids. ASMq treatment showed increased glutamine and reduced carnitine, glycoprotein, formate, and phenylalanine levels (P < 0.05). CONCLUSION: Low immune function, decreased oxidative defense, liver function abnormalities, amino acid deficiencies, and energy metabolism disorders are common characteristics of abnormal Savda-related diseases. ASMq may improve the abnormal metabolism and immune function of rat models with different diseases combined abnormal Savda. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4621637/ /pubmed/26600713 http://dx.doi.org/10.4103/0973-1296.165551 Text en Copyright: © Pharmacognosy Magazine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution NonCommercial ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Mamtimin, Batur
Xia, Guo
Mijit, Mahmut
Hizbulla, Mawlanjan
Kurbantay, Nazuk
You, Li
Upur, Halmurat
Metabolic differentiation and classification of abnormal Savda Munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics
title Metabolic differentiation and classification of abnormal Savda Munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics
title_full Metabolic differentiation and classification of abnormal Savda Munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics
title_fullStr Metabolic differentiation and classification of abnormal Savda Munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics
title_full_unstemmed Metabolic differentiation and classification of abnormal Savda Munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics
title_short Metabolic differentiation and classification of abnormal Savda Munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics
title_sort metabolic differentiation and classification of abnormal savda munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621637/
https://www.ncbi.nlm.nih.gov/pubmed/26600713
http://dx.doi.org/10.4103/0973-1296.165551
work_keys_str_mv AT mamtiminbatur metabolicdifferentiationandclassificationofabnormalsavdamunziqspharmacodynamicroleonratmodelswithdifferentdiseasesbynuclearmagneticresonancebasedmetabonomics
AT xiaguo metabolicdifferentiationandclassificationofabnormalsavdamunziqspharmacodynamicroleonratmodelswithdifferentdiseasesbynuclearmagneticresonancebasedmetabonomics
AT mijitmahmut metabolicdifferentiationandclassificationofabnormalsavdamunziqspharmacodynamicroleonratmodelswithdifferentdiseasesbynuclearmagneticresonancebasedmetabonomics
AT hizbullamawlanjan metabolicdifferentiationandclassificationofabnormalsavdamunziqspharmacodynamicroleonratmodelswithdifferentdiseasesbynuclearmagneticresonancebasedmetabonomics
AT kurbantaynazuk metabolicdifferentiationandclassificationofabnormalsavdamunziqspharmacodynamicroleonratmodelswithdifferentdiseasesbynuclearmagneticresonancebasedmetabonomics
AT youli metabolicdifferentiationandclassificationofabnormalsavdamunziqspharmacodynamicroleonratmodelswithdifferentdiseasesbynuclearmagneticresonancebasedmetabonomics
AT upurhalmurat metabolicdifferentiationandclassificationofabnormalsavdamunziqspharmacodynamicroleonratmodelswithdifferentdiseasesbynuclearmagneticresonancebasedmetabonomics